Company Email Format Management

Prilenia

Biotechnology Research Boston, Massachusetts, United States 59 employees

Employees: 59
Contacts: 2
Emails: 2
Phones: 2

prilenia.com LinkedIn Crunchbase

Prilenia Overview

Headquarters: Boston, Massachusetts, United States
Phone Number: Available in AeroLeads
Website: prilenia.com
Industry: Biotechnology Research
Employees: 59
Founded: 2018
Funding: 43.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Prilenia

Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders. Our lead asset is Pridopidine, a first-in-class oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children. Pridopidine is currently being evaluated for the treatment of Huntington’s disease in our global Phase 3 PROOF-HD trial, and for the treatment of ALS in the Phase 2/3 HEALEY platform trial. The company is led by Dr. Michael Hayden, MD, PhD, the founder of five biotech companies and previous President of Global R&D and Chief Scientific Officer at Teva. Michael has directed the development of multiple innovative drug products, leading to 35 approvals between 2012-2018. The Company is based in Naarden, the Netherlands, Herzliya, Israel and Boston, MA in the U.S.

Prilenia Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 2; 50.0% coverage

Prilenia Org Chart

Sample employees and titles

Name	Title	Location	Contact
Eric Litjens, Msc, Phd			View
Nick Ventresca	Head of IT / CIO	United States	Email Phone
Noga G.			View
Bernd-Jan Sanson, M.d.		Bussum, North Holland, Netherlands	Email Phone